scispace - formally typeset
I

Ivica Jeremic

Researcher at University of Belgrade

Publications -  24
Citations -  355

Ivica Jeremic is an academic researcher from University of Belgrade. The author has contributed to research in topics: Internal medicine & Lupus erythematosus. The author has an hindex of 10, co-authored 19 publications receiving 282 citations.

Papers
More filters
Journal ArticleDOI

Anti-inflammatory, gastroprotective, and cytotoxic effects of Sideritis scardica extracts.

TL;DR: It seems that phenolic compounds (apigenin, luteolin, and their corresponding glycosides) are responsible for the diethyl ether extract cytotoxic effect, and induction of oxidative stress might be involved in its cytotoxicity.
Journal ArticleDOI

Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.

TL;DR: A decrease of DNase I activity in SLE flare-ups might be a functional biomarker of a subset of patients with specific dysfunction of apoptotic chromatin degradation, as well as a useful tool in the follow-up of SLE.
Journal ArticleDOI

Evaluation of Anticancer and Antioxidant Activity of a Commercially Available CO2 Supercritical Extract of Old Man's Beard (Usnea barbata).

TL;DR: Investigation of chemical profile and stated biological activities of the supercritical CO2 extract of old man’s beard compared to the extracts obtained using the conventional techniques found a good correlation of usnic acid content in the extracts and their antioxidant capacity was established, extricating SCE as the most active one.
Journal ArticleDOI

Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity

TL;DR: The results suggest that simple and reliable ELISA for high-avidity anti-dsDNA antibodies is the test of good clinical utility for the assessment of global SLE activity.
Journal ArticleDOI

Anti–double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis:

TL;DR: This is the first report of a patient with MS in whom treatment with IFN-β induced lupus syndrome and antibodies to dsDNA and nucleosome is reported, and the patient’s symptoms completely resolved and autoantibodies disappeared.